Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Leishmania | 6 | 2019 | 28 | 4.35 | Why? |
| Trypanosoma cruzi | 8 | 2019 | 133 | 4.11 | Why? |
| Chagas Disease | 7 | 2019 | 155 | 3.20 | Why? |
| DNA, Protozoan | 11 | 2019 | 77 | 2.88 | Why? |
| Leishmaniasis, Cutaneous | 4 | 2018 | 48 | 2.76 | Why? |
| Colombia | 20 | 2021 | 1241 | 2.53 | Why? |
| Blastocystis | 2 | 2019 | 9 | 1.51 | Why? |
| Giardiasis | 2 | 2019 | 34 | 1.51 | Why? |
| Rhodnius | 2 | 2018 | 3 | 1.47 | Why? |
| RNA, Protozoan | 2 | 2017 | 6 | 1.39 | Why? |
| Insect Vectors | 3 | 2019 | 227 | 1.36 | Why? |
| Blastocystis Infections | 3 | 2019 | 12 | 1.09 | Why? |
| Genetic Variation | 6 | 2021 | 3919 | 1.01 | Why? |
| Indians, South American | 2 | 2021 | 126 | 0.99 | Why? |
| Parasite Load | 2 | 2018 | 15 | 0.93 | Why? |
| Intestinal Diseases, Parasitic | 2 | 2019 | 34 | 0.93 | Why? |
| Cryptosporidiosis | 2 | 2019 | 46 | 0.93 | Why? |
| RNA, Ribosomal, 18S | 2 | 2019 | 68 | 0.88 | Why? |
| Antimony Sodium Gluconate | 1 | 2019 | 1 | 0.83 | Why? |
| Triatominae | 1 | 2019 | 5 | 0.81 | Why? |
| Cyclospora | 1 | 2018 | 2 | 0.79 | Why? |
| Giardia lamblia | 1 | 2018 | 20 | 0.77 | Why? |
| Military Personnel | 2 | 2021 | 1097 | 0.76 | Why? |
| Leishmania donovani | 1 | 2018 | 15 | 0.76 | Why? |
| Antiprotozoal Agents | 1 | 2019 | 83 | 0.76 | Why? |
| Toxoplasma | 1 | 2018 | 61 | 0.75 | Why? |
| Psychodidae | 1 | 2018 | 16 | 0.74 | Why? |
| Leishmaniasis | 1 | 2018 | 26 | 0.73 | Why? |
| Chromatography, Ion Exchange | 1 | 2017 | 13 | 0.73 | Why? |
| Carrier State | 2 | 2020 | 2100 | 0.72 | Why? |
| Parasitemia | 1 | 2018 | 88 | 0.72 | Why? |
| Toxoplasmosis | 1 | 2018 | 59 | 0.72 | Why? |
| Leishmania guyanensis | 1 | 2017 | 2 | 0.71 | Why? |
| Arboviruses | 1 | 2018 | 76 | 0.71 | Why? |
| Leishmania braziliensis | 1 | 2017 | 10 | 0.70 | Why? |
| Acanthamoeba Keratitis | 1 | 2017 | 15 | 0.70 | Why? |
| Topography, Medical | 1 | 2017 | 45 | 0.70 | Why? |
| Trypanosoma brucei brucei | 1 | 2017 | 9 | 0.70 | Why? |
| South America | 4 | 2021 | 565 | 0.69 | Why? |
| Leishmaniasis, Visceral | 1 | 2018 | 85 | 0.68 | Why? |
| Acanthamoeba | 1 | 2017 | 36 | 0.67 | Why? |
| Arbovirus Infections | 1 | 2018 | 104 | 0.67 | Why? |
| DNA Barcoding, Taxonomic | 1 | 2017 | 39 | 0.67 | Why? |
| Real-Time Polymerase Chain Reaction | 5 | 2019 | 11367 | 0.65 | Why? |
| Life Cycle Stages | 1 | 2017 | 162 | 0.64 | Why? |
| Drinking Water | 1 | 2018 | 145 | 0.64 | Why? |
| Drug Resistance | 1 | 2019 | 395 | 0.64 | Why? |
| Host-Parasite Interactions | 1 | 2017 | 112 | 0.63 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.62 | Why? |
| Alleles | 2 | 2019 | 1557 | 0.61 | Why? |
| Plant Leaves | 1 | 2017 | 233 | 0.60 | Why? |
| Contact Lenses | 1 | 2017 | 108 | 0.60 | Why? |
| Pets | 1 | 2019 | 314 | 0.59 | Why? |
| Chikungunya virus | 1 | 2018 | 339 | 0.58 | Why? |
| Transcriptome | 2 | 2019 | 3466 | 0.56 | Why? |
| Dog Diseases | 2 | 2018 | 745 | 0.55 | Why? |
| Chikungunya Fever | 1 | 2018 | 345 | 0.54 | Why? |
| Polymorphism, Genetic | 1 | 2021 | 1074 | 0.51 | Why? |
| Phylogeography | 1 | 2017 | 824 | 0.51 | Why? |
| Phylogeny | 8 | 2021 | 13341 | 0.48 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.45 | Why? |
| Genotype | 6 | 2019 | 4697 | 0.45 | Why? |
| Diagnostic Tests, Routine | 2 | 2021 | 2643 | 0.43 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.42 | Why? |
| DNA, Ribosomal | 3 | 2019 | 112 | 0.41 | Why? |
| Molecular Typing | 2 | 2019 | 280 | 0.32 | Why? |
| Disease Vectors | 2 | 2018 | 208 | 0.31 | Why? |
| Animals | 16 | 2021 | 78931 | 0.31 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.29 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.29 | Why? |
| Travel | 2 | 2020 | 7220 | 0.27 | Why? |
| Sensitivity and Specificity | 6 | 2021 | 22971 | 0.27 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.27 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2018 | 3388 | 0.26 | Why? |
| Molecular Epidemiology | 2 | 2019 | 1638 | 0.25 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.24 | Why? |
| Dogs | 3 | 2019 | 2529 | 0.24 | Why? |
| Rainforest | 1 | 2020 | 37 | 0.22 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.21 | Why? |
| Humans | 34 | 2021 | 930598 | 0.21 | Why? |
| Venezuela | 1 | 2020 | 172 | 0.21 | Why? |
| Feces | 3 | 2019 | 4235 | 0.21 | Why? |
| Helminthiasis | 1 | 2021 | 78 | 0.21 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.21 | Why? |
| Entamoebiasis | 1 | 2019 | 10 | 0.20 | Why? |
| Ovum | 1 | 2018 | 35 | 0.19 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.19 | Why? |
| Trypanosoma | 1 | 2018 | 3 | 0.19 | Why? |
| DEAE-Dextran | 1 | 2017 | 2 | 0.18 | Why? |
| Sepharose | 1 | 2017 | 12 | 0.18 | Why? |
| Gene Ontology | 1 | 2019 | 391 | 0.17 | Why? |
| Arecaceae | 1 | 2017 | 11 | 0.17 | Why? |
| Insect Control | 1 | 2017 | 17 | 0.17 | Why? |
| Ribotyping | 1 | 2017 | 54 | 0.17 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 449 | 0.17 | Why? |
| Mice, Inbred ICR | 1 | 2017 | 242 | 0.17 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.17 | Why? |
| Diptera | 1 | 2017 | 30 | 0.17 | Why? |
| Egypt | 1 | 2021 | 1211 | 0.16 | Why? |
| Gene Expression Profiling | 2 | 2019 | 3788 | 0.16 | Why? |
| Genotyping Techniques | 1 | 2019 | 360 | 0.16 | Why? |
| Birds | 1 | 2019 | 412 | 0.15 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.15 | Why? |
| Molecular Biology | 1 | 2018 | 139 | 0.15 | Why? |
| Microscopy | 1 | 2019 | 414 | 0.15 | Why? |
| Microarray Analysis | 1 | 2017 | 262 | 0.15 | Why? |
| Water Purification | 1 | 2018 | 285 | 0.14 | Why? |
| Spatial Analysis | 1 | 2021 | 878 | 0.14 | Why? |
| Tropical Medicine | 1 | 2017 | 237 | 0.14 | Why? |
| North America | 1 | 2019 | 1400 | 0.14 | Why? |
| Haplotypes | 1 | 2018 | 853 | 0.14 | Why? |
| Armed Conflicts | 1 | 2017 | 209 | 0.14 | Why? |
| Geography, Medical | 1 | 2017 | 537 | 0.13 | Why? |
| Fertility | 1 | 2018 | 367 | 0.13 | Why? |
| Geography | 1 | 2020 | 1801 | 0.13 | Why? |
| Datasets as Topic | 1 | 2021 | 1404 | 0.13 | Why? |
| Neglected Diseases | 1 | 2018 | 381 | 0.13 | Why? |
| Argentina | 1 | 2017 | 1141 | 0.12 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.12 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.12 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.12 | Why? |
| Sequence Analysis, DNA | 2 | 2018 | 2830 | 0.11 | Why? |
| Spatio-Temporal Analysis | 1 | 2018 | 1182 | 0.11 | Why? |
| Male | 11 | 2021 | 367725 | 0.11 | Why? |
| Ecosystem | 1 | 2017 | 776 | 0.11 | Why? |
| Female | 11 | 2021 | 380317 | 0.11 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.11 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.11 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.11 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.11 | Why? |
| Sequence Analysis, RNA | 1 | 2019 | 2290 | 0.10 | Why? |
| Transients and Migrants | 1 | 2021 | 1468 | 0.09 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.09 | Why? |
| Prevalence | 3 | 2019 | 25773 | 0.09 | Why? |
| Mice | 2 | 2018 | 21357 | 0.09 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.09 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.09 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.08 | Why? |
| Adult | 6 | 2021 | 244371 | 0.08 | Why? |
| Feeding Behavior | 1 | 2019 | 1909 | 0.08 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.08 | Why? |
| Cities | 1 | 2018 | 4937 | 0.08 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.07 | Why? |
| Databases, Factual | 1 | 2020 | 6248 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.07 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.07 | Why? |
| Asymptomatic Diseases | 1 | 2017 | 3444 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Chiroptera | 1 | 2018 | 3530 | 0.06 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.06 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.05 | Why? |
| Vero Cells | 1 | 2017 | 14117 | 0.05 | Why? |
| Mutation | 1 | 2020 | 12376 | 0.05 | Why? |
| Child | 2 | 2021 | 70012 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.05 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.04 | Why? |
| Infant | 1 | 2021 | 30274 | 0.04 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.04 | Why? |
| Th2 Cells | 1 | 2021 | 680 | 0.04 | Why? |
| Benchmarking | 1 | 2021 | 627 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| Coinfection | 1 | 2017 | 6820 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Th1 Cells | 1 | 2021 | 1228 | 0.04 | Why? |
| Cathepsin L | 1 | 2018 | 566 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Aged | 2 | 2021 | 215776 | 0.03 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2017 | 1672 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Brazil | 1 | 2018 | 12582 | 0.01 | Why? |